Literature DB >> 23228177

Intestinal dysbacteriosis induces changes of T lymphocyte subpopulations in Peyer's patches of mice and orients the immune response towards humoral immunity.

Fei Gao1, Ming Li, Yinhui Liu, Chuanzhou Gao, Shu Wen, Li Tang.   

Abstract

The large numbers of human intestinal microorganisms have a highly co-evolved relationship with the immune system. Dysbacteriosis of intestinal microbiota induces alterations of immune responses, and is closely related to disease development. Peyer's patches are immune sensors in intestine which exert essential functions during development of inflammatory disease. However, interactions between commensal bacteria and PPs have been poorly characterized. In this study, changes of lymphocyte subpopulations and production of cytokines in PPs of mice with intestinal dysbacteriosis were investigated. The ceftriaxone-induced dysbacteriosis caused a notable change in populations of T lymphocytes, their subpopulations in PPs and expressions of various cytokines. Our results suggest intestinal dysbacteriosis in mice reduces immune tolerance in PPs and orients immune response towards humoral immunity.

Entities:  

Year:  2012        PMID: 23228177      PMCID: PMC3583793          DOI: 10.1186/1757-4749-4-19

Source DB:  PubMed          Journal:  Gut Pathog        ISSN: 1757-4749            Impact factor:   4.181


Background

Intestinal microorganisms are required for proper development of the immune system, as indicated by the fact that germ-free (GF) mice have poorly developed lymphoid tissues [1]. Under normal conditions, gut microflora exists in a state of equilibrium with host that is mutually beneficial to the degree that it has been described as a separate ‘organ’ adapted to human physiology [2]. However, factors such as antibiotics abuse, stress, or nutritional deficiencies can seriously disrupt this delicate balance, resulting in altered immune responses and disease. In IBD patients, the quantity of commensal bacteria in the intestine is reduced, diversity of microbiota is also altered [3,4]. Patients with IBD exhibit disruption in mucosal integrity, dysfunction of gut-associated lymphoid tissue (GALT), and deregulated immune tolerance [5,6]. Nevertheless, whether microbial dysbiosis in the gut is the cause of dysfunction in GALT, and of reduced immune tolerance, are as yet poorly documented. Peyer’s patches (PPs) are major component of GALT. Lacking of PPs and lymph nodes would develop more severe colitis in mice [7], suggesting PPs’ importance in exerting immune functions during the development of IBD. The participation of PPs in inflammatory disorders and their interplay with gut microbiota is thus becoming an interesting field of research.

Study design and results

We hypothesized that alterations in gut microflora may induce changes of cellular composition and cytokine productions in PPs, and lead to a shift in immune response/tolerance. To test this, we established mouse models with dysbacteriosis through intragastric administration of ceftriaxone sodium. Alterations of lymphocytes in PPs (particularly the T lymphocyte subpopulations) were examined, as was cytokine mRNA expression (Additional file 1: Supplementary material). The population of commensal bacteria was found reduced in mice treated with ceftriaxone sodium and some are even eradicated (Additional file 2: Table S1). The structure of intestinal microflora was seriously disrupted. The population of CD3+ T cells, which represents the level of cell-mediated immune response, was detected by flow cytometry. Compared with control mice, the total level of CD3+ T cells in PPs of mild dysbacteriosis mice increased to 22.2%, and to 26.9% in PPs of the severe group (Figure 1a). The T lymphocyte subpopulations were also examined. Results in Figure 1b show that CD4+ T cells in PPs of mild and severe dysbacteriosis mice increased by 7.37% and 5.15%, respectively. In contrast, the CD8+ T cells in PPs of mice with dysbacteriosis decreased from 5.85% to no more than 3.60%, resulting in a higher ratio of CD4+/CD8+ compared with healthy mice (Figure 1c). Changes in CD4+/CD8+ ratio are normally considered as an important reference to predict the shifting of immune responses. The increased proportion of CD4+/CD8+ indicates that intestinal dysbacteriosis has induced humoral immunity in mice. The populations of CD4+CD25+ T cells in PPs of healthy and dysbacteriosis mice were also detected. CD4+CD25+ are marker molecules on the surface of regulatory T cells (Treg cells), which are crucial for maintenance of immunological tolerance [8]. In PPs of dysbacteriosis mice groups, the regulatory CD4+CD25+ T cells were severely decreased (Figure 1c). These striking decreases indicate a significant reduction of immunological tolerance. The transforming growth factor-beta (TGF-β) is a critical regulator for the development of Treg cells, which are crucial for the maintenance of immunological tolerance [9]; we therefore detected the mRNA expression levels of TGF-β gene. As shown in Figure 2, a decreasing pattern was observed in dysbacteriosis mice groups, which suggested a delay of Treg cells development. This is basically correlated with the trends that have seen for the population of CD4+CD25+ T cells. Th cells represent a functionally heterogeneous population, comprising mainly two distinct subsets (termed Th1 and Th2 cells), defined by their cytokine secretion profiles [20]. Th1 cells produce IL-2, IFN-γ and tumour necrosis factor-beta (TNF-β), and promote both macrophage activation, and the production of complement fixing and opsonising antibodies. Th2 cells, which synthesize cytokines such as IL-4, IL-10 and etc., provide optimal help for antibody production, promote mast cell growth, eosinophil differentiation and activation, resulting in humoral or allergic responses [10]. In the present study, a slight decrease (by 10.7%) of Il2 gene expression was observed in PPs of mice with mild dysbacteriosis, while a dramatic decrease (by 60.9%) was observed in the severe group (Figure 2). The mRNA levels of the Ifng gene also decreased (by 20.4% and 37.4%, respectively). Expression of the Il4 gene in PPs of mice with mild dysbacteriosis increased by 23.6% compared with control, and it was 36.4% higher in the severe group. Expression of the Il10 gene increased dramatically in PPs of both mild (by 98.9%) and severe (by 200.4%) groups. The decrease in mRNA levels of Il2 and Ifng in PPs of dysbacteriosis mice suggest activation and proliferation of Th2 cells, while the elevation of Il4 and Il10 inhibit Th1 cells. Results in Figure 2 thus support the observation that dysbacteriosis in mice has induced a shifting of immune responses in PPs towards humoral immunity.
Figure 1

Changing of lymphocyte population and subpopulations in PPs of different experimental groups.a), Percentage of CD3+ T cells among total cells; b), Percentage of CD4+ and CD8+ cells among CD3+ T cells; c), The proportion of CD4+/CD8+ ; d), Percentage of CD4+CD25+ T cells among CD3+ T cells. *, p<0.05, compared with control group; Δ, p<0.05, compared with mild group. Five BALB/c mice were administered intra-gastrically with 0.2 mL of ceftriaxone sodium (200 mg/mL or 400 mg/mL) twice a day with an interval of 6 hours for 4 or 8 days to establish the mild or severe intestinal dysbacteriosis mouse models. Five BALB/c mice treated with sterile water instead of ceftriaxone sodium served as control (Details in Additional file 1: Supplementary material).

Figure 2

The expression levels of mRNA for cytokines. The relative mRNA abundance of cytokines in PPs of different experimental groups was detected by Reverse-transcript PCR (Details in Additional file 1: Supplementary material and methods). Tgfb, transforming growth factor-beta; Il2, interleukin-2; Ifng, interferon-gamma; Il4, interleukin-4; Il10, interleukin-10. The relative mRNA abundence is determined by dividing the intensity of cytokine PCR products with the intensity of β-actin PCR product. Values are means±SEM (n=3).

Changing of lymphocyte population and subpopulations in PPs of different experimental groups.a), Percentage of CD3+ T cells among total cells; b), Percentage of CD4+ and CD8+ cells among CD3+ T cells; c), The proportion of CD4+/CD8+ ; d), Percentage of CD4+CD25+ T cells among CD3+ T cells. *, p<0.05, compared with control group; Δ, p<0.05, compared with mild group. Five BALB/c mice were administered intra-gastrically with 0.2 mL of ceftriaxone sodium (200 mg/mL or 400 mg/mL) twice a day with an interval of 6 hours for 4 or 8 days to establish the mild or severe intestinal dysbacteriosis mouse models. Five BALB/c mice treated with sterile water instead of ceftriaxone sodium served as control (Details in Additional file 1: Supplementary material). The expression levels of mRNA for cytokines. The relative mRNA abundance of cytokines in PPs of different experimental groups was detected by Reverse-transcript PCR (Details in Additional file 1: Supplementary material and methods). Tgfb, transforming growth factor-beta; Il2, interleukin-2; Ifng, interferon-gamma; Il4, interleukin-4; Il10, interleukin-10. The relative mRNA abundence is determined by dividing the intensity of cytokine PCR products with the intensity of β-actin PCR product. Values are means±SEM (n=3).

Conclusions

The present work describes the effects of intestinal dysbacteriosis on immune responses of PPs in mice. This disturbance in mice can be induced by ceftriaxone sodium, making it an ideal animal model to mimic gut dysbacteriosis in human. Also, this is the first study to document changes in T lymphocyte subpopulations and cytokine mRNA expression of PPs in response to intestinal dysbacteriosis. Dysbacteriosis induced a notable change in overall population of T lymphocytes, and in T lymphocyte subpopulations, in PPs, as well as altering the mRNA expression of various cytokines. These data suggest that immune tolerance in PPs is reduced after the administration of antibiotics, and the immune response has shifted to humoral immunity. However, relevance of these observations requires further study.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

LT and SW designed the research; FG and ML performed the experiments; ML and YL analyzed the data; ML, CG, SW and LT wrote this paper. FG and ML contributed equally to this work. All authors read and approved the final manuscript.

Additional file 1

Supplementary material and methods. Click here for file

Additional file 2

Table S1. The population of commensal bacteria in cecal contents of mice. Click here for file
  10 in total

1.  Induction of colitis in mice deficient of Peyer's patches and mesenteric lymph nodes is associated with increased disease severity and formation of colonic lymphoid patches.

Authors:  Thomas W Spahn; Hermann Herbst; Paul D Rennert; Norbert Lügering; Christian Maaser; Mathias Kraft; Adriano Fontana; Howard L Weiner; Wolfram Domschke; Torsten Kucharzik
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

Review 2.  An integrated view of suppressor T cell subsets in immunoregulation.

Authors:  Hong Jiang; Leonard Chess
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

3.  Diversity of the human intestinal microbial flora.

Authors:  Paul B Eckburg; Elisabeth M Bik; Charles N Bernstein; Elizabeth Purdom; Les Dethlefsen; Michael Sargent; Steven R Gill; Karen E Nelson; David A Relman
Journal:  Science       Date:  2005-04-14       Impact factor: 47.728

4.  Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach.

Authors:  C Manichanh; L Rigottier-Gois; E Bonnaud; K Gloux; E Pelletier; L Frangeul; R Nalin; C Jarrin; P Chardon; P Marteau; J Roca; J Dore
Journal:  Gut       Date:  2005-09-27       Impact factor: 23.059

5.  Induction of colonic regulatory T cells by indigenous Clostridium species.

Authors:  Koji Atarashi; Takeshi Tanoue; Tatsuichiro Shima; Akemi Imaoka; Tomomi Kuwahara; Yoshika Momose; Genhong Cheng; Sho Yamasaki; Takashi Saito; Yusuke Ohba; Tadatsugu Taniguchi; Kiyoshi Takeda; Shohei Hori; Ivaylo I Ivanov; Yoshinori Umesaki; Kikuji Itoh; Kenya Honda
Journal:  Science       Date:  2010-12-23       Impact factor: 47.728

6.  Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus.

Authors:  Norihiko Watanabe; Yi-Hong Wang; Heung Kyu Lee; Tomoki Ito; Yui-Hsi Wang; Wei Cao; Yong-Jun Liu
Journal:  Nature       Date:  2005-08-25       Impact factor: 49.962

Review 7.  Inflammatory bowel disease: dysfunction of GALT and gut bacterial flora (II).

Authors:  P Chandran; S Satthaporn; A Robins; O Eremin
Journal:  Surgeon       Date:  2003-06       Impact factor: 2.392

Review 8.  Inflammatory bowel disease: dysfunction of GALT and gut bacterial flora (I).

Authors:  P Chandran; S Satthaporn; A Robins; O Eremin
Journal:  Surgeon       Date:  2003-04       Impact factor: 2.392

9.  Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease.

Authors:  S J Ott; M Musfeldt; D F Wenderoth; J Hampe; O Brant; U R Fölsch; K N Timmis; S Schreiber
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

10.  Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases.

Authors:  Daniel N Frank; Allison L St Amand; Robert A Feldman; Edgar C Boedeker; Noam Harpaz; Norman R Pace
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-15       Impact factor: 11.205

  10 in total
  7 in total

1.  Intestinal Microbiota Is Altered in Patients with Gastric Cancer from Shanxi Province, China.

Authors:  Yu-Feng Qi; Jun-Ning Sun; Lai-Feng Ren; Xue-Ling Cao; Jian-Hong Dong; Kai Tao; Xue-Mei Guan; Ya-Ni Cui; Wen Su
Journal:  Dig Dis Sci       Date:  2018-12-07       Impact factor: 3.199

2.  The Anti-Inflammatory Effect and Intestinal Barrier Protection of HU210 Differentially Depend on TLR4 Signaling in Dextran Sulfate Sodium-Induced Murine Colitis.

Authors:  Sisi Lin; Yongyu Li; Li Shen; Ruiqin Zhang; Lizhi Yang; Min Li; Kun Li; Jakub Fichna
Journal:  Dig Dis Sci       Date:  2016-12-19       Impact factor: 3.199

3.  Clostridium butyricum combined with Bifidobacterium infantis probiotic mixture restores fecal microbiota and attenuates systemic inflammation in mice with antibiotic-associated diarrhea.

Authors:  Zongxin Ling; Xia Liu; Yiwen Cheng; Yueqiu Luo; Li Yuan; Lanjuan Li; Charlie Xiang
Journal:  Biomed Res Int       Date:  2015-02-23       Impact factor: 3.411

4.  Intestinal Peyer's patches prevent tumorigenesis in Apc (Min/+) mice.

Authors:  Kyoko Fujimoto; Gen Fujii; Hitomi Sakurai; Hiroko Yoshitome; Michihiro Mutoh; Morimasa Wada
Journal:  J Clin Biochem Nutr       Date:  2014-11-28       Impact factor: 3.114

5.  The Anti-Inflammatory Effect and Mucosal Barrier Protection of Clostridium butyricum RH2 in Ceftriaxone-Induced Intestinal Dysbacteriosis.

Authors:  Yuyuan Li; Man Liu; He Liu; Xue Sui; Yinhui Liu; Xiaoqing Wei; Chunzheng Liu; Yiqin Cheng; Weikang Ye; Binbin Gao; Xin Wang; Qiao Lu; Hao Cheng; Lu Zhang; Jieli Yuan; Ming Li
Journal:  Front Cell Infect Microbiol       Date:  2021-03-25       Impact factor: 5.293

6.  Experimental postoperative ileus: is Th2 immune response involved?

Authors:  Sisi Lin; Florian Kühn; Tobias S Schiergens; Andrey A Zamyatnin; Orkhan Isayev; Eldar Gasimov; Jens Werner; Yongyu Li; Alexandr V Bazhin
Journal:  Int J Med Sci       Date:  2021-06-16       Impact factor: 3.738

7.  Biotic acts of antibiotics.

Authors:  Rustam I Aminov
Journal:  Front Microbiol       Date:  2013-08-19       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.